Cochrane Abstracts
Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Inhaled Corticosteroids Versus Long‐acting Beta2‐agonists for Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/Inhaled_corticosteroids_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease. Accessed 01 October 2023.
Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/Inhaled_corticosteroids_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease. Accessed October 1, 2023.
Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/Inhaled_corticosteroids_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease
Inhaled Corticosteroids Versus Long‐acting Beta2‐agonists for Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. [cited 2023 October 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/Inhaled_corticosteroids_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
ID - 431603
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/Inhaled_corticosteroids_versus_long‐acting_beta2‐agonists_for_chronic_obstructive_pulmonary_disease
DB - Evidence Central
DP - Unbound Medicine
ER -
